BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17721024)

  • 1. Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation: single center experience.
    Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kawauchi K; Yamada T; Kofune T; Hashimoto K; Shindo A; Sugimura H; Nakai T; Saito S; Hirayama A
    Circ J; 2007 Sep; 71(9):1437-41. PubMed ID: 17721024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.
    Kanda M; Shimizu W; Matsuo K; Nagaya N; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(11):1799-805. PubMed ID: 12039494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular repolarization restitution properties in patients exhibiting type 1 Brugada electrocardiogram with and without inducible ventricular fibrillation.
    Hayashi M; Takatsuki S; Maison-Blanche P; Messali A; Haggui A; Milliez P; Leenhardt A; Extramiana F
    J Am Coll Cardiol; 2008 Mar; 51(12):1162-8. PubMed ID: 18355653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram.
    Makimoto H; Kamakura S; Aihara N; Noda T; Nakajima I; Yokoyama T; Doi A; Kawata H; Yamada Y; Okamura H; Satomi K; Aiba T; Shimizu W
    Heart Rhythm; 2012 Feb; 9(2):242-8. PubMed ID: 21939629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome.
    Morita H; Miyamoto M; Watanabe A; Tsukuda S; Morimoto Y; Kawada S; Nakagawa K; Nishii N; Ito H
    Heart Rhythm; 2018 Oct; 15(10):1468-1474. PubMed ID: 29953954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.
    Brugada P; Brugada R; Mont L; Rivero M; Geelen P; Brugada J
    J Cardiovasc Electrophysiol; 2003 May; 14(5):455-7. PubMed ID: 12776858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface ECG characteristics of ventricular tachyarrhythmias before degeneration into ventricular fibrillation in patients with Brugada-type ECG.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Ohta M; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2009 Jul; 50(4):477-87. PubMed ID: 19609052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
    Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indication and prognostic significance of programmed ventricular stimulation in asymptomatic patients with Brugada syndrome.
    Asada S; Morita H; Watanabe A; Nakagawa K; Nagase S; Miyamoto M; Morimoto Y; Kawada S; Nishii N; Ito H
    Europace; 2020 Jun; 22(6):972-979. PubMed ID: 32167564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific arrhythmogenesis in patients with Brugada syndrome.
    Morita H; Fukushima-Kusano K; Nagase S; Takenaka-Morita S; Nishii N; Kakishita M; Nakamura K; Emori T; Matsubara H; Ohe T
    J Cardiovasc Electrophysiol; 2003 Apr; 14(4):373-9. PubMed ID: 12741708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of induced ventricular fibrillation cycle length in symptomatic Brugada syndrome patients.
    Hiratsuka A; Shimizu A; Ueyama T; Yoshiga Y; Doi M; Ohmiya T; Yoshida M; Fukuda M; Matsuzaki M
    Circ J; 2012; 76(3):624-33. PubMed ID: 22251750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro).
    Shimizu A
    Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the Brugada-type electrocardiogram and incidence of Brugada syndrome in patients with sick sinus syndrome.
    Hayashi H; Sumiyoshi M; Yasuda M; Komatsu K; Sekita G; Kawano Y; Tokano T; Nakazato Y; Daida H
    Circ J; 2010 Feb; 74(2):271-7. PubMed ID: 20019410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.